These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 30967262)

  • 41. Liraglutide improved inflammation
    Chen P; Lin L; Xu X; Zhang Z; Cai W; Shao Z; Chen S; Chen X; Weng Q
    J Dermatolog Treat; 2021 Nov; 32(7):745-751. PubMed ID: 31868553
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Imiquimod has strain-dependent effects in mice and does not uniquely model human psoriasis.
    Swindell WR; Michaels KA; Sutter AJ; Diaconu D; Fritz Y; Xing X; Sarkar MK; Liang Y; Tsoi A; Gudjonsson JE; Ward NL
    Genome Med; 2017 Mar; 9(1):24. PubMed ID: 28279190
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TLR2 Deficiency Exacerbates Imiquimod-Induced Psoriasis-Like Skin Inflammation through Decrease in Regulatory T Cells and Impaired IL-10 Production.
    Nakao M; Sugaya M; Fujita H; Miyagaki T; Morimura S; Shibata S; Asano Y; Sato S
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202847
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activation of Langerhans cells promotes the inflammation in imiquimod-induced psoriasis-like dermatitis.
    Xiao C; Zhu Z; Sun S; Gao J; Fu M; Liu Y; Wang G; Yao X; Li W
    J Dermatol Sci; 2017 Mar; 85(3):170-177. PubMed ID: 27964879
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulation of IL-22BP in psoriasis.
    Voglis S; Moos S; Kloos L; Wanke F; Zayoud M; Pelczar P; Giannou AD; Pezer S; Albers M; Luessi F; Huber S; Schäkel K; Kurschus FC
    Sci Rep; 2018 Mar; 8(1):5085. PubMed ID: 29572462
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An alternative pathway of imiquimod-induced psoriasis-like skin inflammation in the absence of interleukin-17 receptor a signaling.
    El Malki K; Karbach SH; Huppert J; Zayoud M; Reissig S; Schüler R; Nikolaev A; Karram K; Münzel T; Kuhlmann CR; Luhmann HJ; von Stebut E; Wörtge S; Kurschus FC; Waisman A
    J Invest Dermatol; 2013 Feb; 133(2):441-51. PubMed ID: 22951726
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of spleen tyrosine kinase attenuates psoriasis-like inflammation in mice through blockade of dendritic cell-Th17 inflammation axis.
    Alzahrani KS; Nadeem A; Ahmad SF; Al-Harbi NO; Ibrahim KE; El-Sherbeeny AM; Alhoshani AR; Alshammari MA; Alotaibi MR; Al-Harbi MM
    Biomed Pharmacother; 2019 Mar; 111():347-358. PubMed ID: 30593001
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intermittent fasting alleviates IMQ-induced psoriasis-like dermatitis via reduced γδT17 and monocytes in mice.
    Chen X; Fu C; Zheng Y; Li X; Liao Y; Zheng Y; Liang W; Zhao Y; Huang J; Huang T; Bu J; Shen E
    Arch Dermatol Res; 2024 May; 316(5):176. PubMed ID: 38758283
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ameliorative effects of topical ramelteon on imiquimod-induced psoriasiform inflammation in mice.
    Khafaji AWM; Al-Zubaidy AAK; Farhood IG; Salman HR
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Aug; 397(8):6231-6248. PubMed ID: 38446218
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting L-type amino acid transporter 1 in innate and adaptive T cells efficiently controls skin inflammation.
    Cibrian D; Castillo-González R; Fernández-Gallego N; de la Fuente H; Jorge I; Saiz ML; Punzón C; Ramírez-Huesca M; Vicente-Manzanares M; Fresno M; Daudén E; Fraga-Fernandez J; Vazquez J; Aragonés J; Sánchez-Madrid F
    J Allergy Clin Immunol; 2020 Jan; 145(1):199-214.e11. PubMed ID: 31605740
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dynamics and Transcriptomics of Skin Dendritic Cells and Macrophages in an Imiquimod-Induced, Biphasic Mouse Model of Psoriasis.
    Terhorst D; Chelbi R; Wohn C; Malosse C; Tamoutounour S; Jorquera A; Bajenoff M; Dalod M; Malissen B; Henri S
    J Immunol; 2015 Nov; 195(10):4953-61. PubMed ID: 26466959
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High-fat diet exacerbates imiquimod-induced psoriasis-like dermatitis in mice.
    Higashi Y; Yamakuchi M; Fukushige T; Ibusuki A; Hashiguchi T; Kanekura T
    Exp Dermatol; 2018 Feb; 27(2):178-184. PubMed ID: 29247486
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oral Administration of Vanillin Improves Imiquimod-Induced Psoriatic Skin Inflammation in Mice.
    Cheng HM; Chen FY; Li CC; Lo HY; Liao YF; Ho TY; Hsiang CY
    J Agric Food Chem; 2017 Nov; 65(47):10233-10242. PubMed ID: 29073354
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Toll-Like Receptor 7 Agonist-Induced Dermatitis Causes Severe Dextran Sulfate Sodium Colitis by Altering the Gut Microbiome and Immune Cells.
    Kiyohara H; Sujino T; Teratani T; Miyamoto K; Arai MM; Nomura E; Harada Y; Aoki R; Koda Y; Mikami Y; Mizuno S; Naganuma M; Hisamatsu T; Kanai T
    Cell Mol Gastroenterol Hepatol; 2019; 7(1):135-156. PubMed ID: 30510995
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Topical histone deacetylase 1 inhibitor Entinostat ameliorates psoriasiform dermatitis through suppression of IL-17A response.
    Jiang Y; Lu S; Lai Y; Wang L
    J Dermatol Sci; 2023 Jun; 110(3):89-98. PubMed ID: 37173222
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of MyD88 signaling in the imiquimod-induced mouse model of psoriasis: focus on innate myeloid cells.
    Costa S; Marini O; Bevilacqua D; DeFranco AL; Hou B; Lonardi S; Vermi W; Rodegher P; Panato A; Tagliaro F; Lowell CA; Cassatella MA; Girolomoni G; Scapini P
    J Leukoc Biol; 2017 Sep; 102(3):791-803. PubMed ID: 28642279
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Matrine alleviates imiquimod-induced psoriasiform dermatitis in BALB/c mice via dendritic cell regulation.
    Li N; Zhao J; Di T; Meng Y; Wang M; Li X; Liu Z; Zhai C; Zhang L; Ma C; Wang Y; Li P
    Int J Clin Exp Pathol; 2018; 11(11):5232-5240. PubMed ID: 31949603
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A requirement for slc15a4 in imiquimod-induced systemic inflammation and psoriasiform inflammation in mice.
    Griffith AD; Zaidi AK; Pietro A; Hadiono M; Yang JS; Davis R; Popkin DL
    Sci Rep; 2018 Sep; 8(1):14451. PubMed ID: 30262916
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CX3CR1 deficiency attenuates imiquimod-induced psoriasis-like skin inflammation with decreased M1 macrophages.
    Morimura S; Oka T; Sugaya M; Sato S
    J Dermatol Sci; 2016 Jun; 82(3):175-88. PubMed ID: 26976687
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-IL-17A ssDNA aptamer ameliorated psoriasis skin lesions in the imiquimod-induced psoriasis mouse model.
    Shobeiri SS; Rezaee M; Pordel S; Haghnnavaz N; Dashti M; Moghadam M; Sankian M
    Int Immunopharmacol; 2022 Sep; 110():108963. PubMed ID: 35724603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.